Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/24 17:31 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Polaris Management Co. Vii, L.L.C. | MA | T | 2 | P.d | 20,000 | 11.00 | 0 | 1,818 | 909 | I | ||||||||||||||||
10/17/24 18:34 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Northpond Ventures II Gp, LLC | MD | T | 1 | P.d | 8,400 | 11.00 | 0 | 764 | 52 | 2,238 | I | |||||||||||||||
10/17/24 17:05 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Ah Equity Partners Bio I, L.L.C. | CA | T | 1 | P.d | 8,000 | 11.00 | 0 | 727 | 52 | 2,125 | I | |||||||||||||||
10/17/24 16:15 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Enavate Sciences Gp, LLC | CA | T | 1 | P.d | 15,000 | 11.00 | 0 | 1,364 | 56 | 3,786 | I | |||||||||||||||
10/15/24 17:56 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | 5Am Partners Vi, LLC | CA | T | 1 | P.d | 10,000 | 11.00 | 0 | 909 | 45 | 2,928 | I | |||||||||||||||
10/15/24 17:49 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Nashat Amir | MA | DT | 1 | P.d | 10,000 | 11.00 | 0 | 909 | 909 | I | ||||||||||||||||
10/15/24 17:48 | 10/15/24 | CAMP | Health | Drug | Pharmaceutical Preparations | Schwab Andrew J. | MA | DT | 1 | P.d | 10,000 | 11.00 | 0 | 909 | 53 | 2,625 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |